Patrick Carpentier

TL;DR: The CEAP classification for chronic venous disorders was developed in 1994 by an international ad hoc committee of the American Venous Forum, endorsed by the Society for Vascular Surgery, and incorporated into "Reporting Standards in Venous Disease" in 1995.

TL;DR: A systematic approach has been developed with recommendations based upon cumulative evidence from the literature, which range from Level I and Grade A to Level III and Grade C, and includes meta-analysis Meta-analyses but there should be caution as to their possible abuse.

TL;DR: The CEAP Task Force has adopted the revised Delphi process and made several changes, including adding Corona phlebectatica as the C4c clinical subclass, introducing the modifier "r" for recurrent varicose veins and recurrent venous ulcers, and replacing numeric descriptions of the venous segments by their common abbreviations.

TL;DR: PDE-5 inhibitors appear to have significant but moderate efficacy in secondary RP, and a further large RCT is needed.

TL;DR: Treatment by ultrasound-guided sclerosis using polidocanol foam seems to be well tolerated and can improve the symptoms of low-flow malformations without the risks of more aggressive sclerosing agents, such as ethanol.